Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting learning session on bridging the gap between AMR surveillance and antibiotic policy for appropriate therapy.
In this webinar, a panel discussion would take place involving Dr Subramanian Swaminathan as the primary speaker and involving other panelists to participate and discuss the important facts associated with antibiotic resistance and the policies to be adapted for introducing an appropriate therapy.
Antimicrobial surveillance is an essential pillar in fighting against antimicrobial resistance (AMR). There is a lack of understanding and practical guidance on how surveillance data should be linked to AMS activities. Moreover, it becomes much more complex in the hospital setting because of the structural heterogeneity of hospital facilities and services.
Therefore, the webinar will give you an overall guidance on bridging the gap between AMR surveillance and antibiotic policy for appropriate therapy. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions
See More Webinars @ Hidoc Webinars
1.
Exercise can counter detrimental effects of cancer treatment, review suggests
2.
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer
3.
New research points out a promising strategy for treating metastatic medulloblastoma
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
Congress Ditched Fix to Medicare Doc Pay Cut in Skinny Budget Bill
1.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
2.
Insights into Doxorubicin and Liposomal Doxorubicin in Extra-Abdominal Desmoid-Type Fibromatosis
3.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
4.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
5.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation